Enhancing patient safety: Materiovigilance and medical device surveillance in India and global perspectives
Main Article Content
Abstract
The post-marketing vigilance system for medical devices in India is not as robust as that for drugs. Materiovigilance, which focuses on monitoring and reporting adverse events associated with medical devices, is an essential aspect of post-marketing surveillance. Various countries, including India, have implemented their own post-marketing surveillance systems in accordance with the World Health Organization’s directives. In India, this system is known as the materiovigilance program of India (MvPI). This article aims to evaluate the current status of MvPI, compare it with the systems in developed countries, and propose specific measures to enhance the effectiveness of the program.
Downloads
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.